What Is The Relationship Between Insulin Resistance And Obesity?

There is a strong and bidirectional relationship between insulin resistance and obesity. Obesity may increase insulin resistance, especially through fat tissue accumulated around the abdomen. Insulin resistance may make weight loss more difficult by affecting appetite control, blood sugar balance and fat storage processes.

This relationship is not limited only to aesthetics or weight management. When insulin resistance and obesity occur together, the risk of type 2 diabetes, prediabetes, metabolic syndrome, fatty liver, hypertension and cardiovascular diseases may increase. Therefore, evaluation should not be based only on the weight on the scale, but also on blood values and metabolic risks.

The World Health Organization defines overweight and obesity as abnormal or excessive fat accumulation that presents a risk to health. Obesity is an important risk factor for noncommunicable diseases such as type 2 diabetes, cardiovascular diseases and some types of cancer. Therefore, when considered together with insulin resistance, obesity should be evaluated as a metabolic health problem that requires regular follow-up.

How Does Obesity Affect Insulin Resistance?

Obesity may negatively affect insulin sensitivity, especially through visceral fat accumulation, meaning fat accumulation around internal organs. Fat tissue is not only an energy store; it is also an active tissue that secretes hormones, inflammatory substances and metabolic signals. This may weaken the response of muscle, liver and fat cells to insulin.

As abdominal fat accumulation increases, the body may have to secrete more insulin to balance blood sugar. At first, blood sugar may appear normal; however, this balance may be maintained with high insulin levels. If the pancreas has difficulty meeting this need over time, the risk of prediabetes or type 2 diabetes may increase.

The main ways obesity may increase insulin resistance include:

• Visceral Fat Accumulation: Fat tissue around internal organs is metabolically active and may negatively affect insulin response.
• Chronic Low-Grade Inflammation: Excess fat tissue may create a continuous and low-grade inflammatory environment in the body.
• Fatty Liver: Fat accumulation in the liver may negatively affect glucose production and insulin response.
• Muscle Tissue Involvement: When physical activity decreases, glucose use by muscles may decrease and insulin sensitivity may fall.
• Hormonal Balance Changes: Some substances secreted from fat tissue may affect appetite, satiety and energy use.

Why Can Insulin Resistance Make Weight Loss Difficult?

In people with insulin resistance, the body may secrete more insulin to balance blood sugar. Insulin is a hormone that affects energy use and fat storage. Therefore, high insulin levels may be seen together with hunger attacks, sweet cravings, post-meal sleepiness and difficulty losing weight in some people.

This does not mean that the person lacks willpower. Metabolic processes, appetite signals and blood sugar fluctuations may make the weight loss process more complex. Therefore, in patients with obesity and insulin resistance, not only calorie calculation but also meal pattern, protein-fiber intake, physical activity, sleep and, when necessary, medical treatment should be evaluated together.

The main mechanisms through which insulin resistance may make weight control difficult include:

• Frequent Hunger: Blood sugar and insulin fluctuations may create hunger again in a shorter time.
• Sweet And Carbohydrate Cravings: Intense carbohydrate cravings may occur, especially in the evening.
• Tendency To Store Fat: High insulin levels may facilitate the storage of excess energy as fat.
• Low Energy: Post-meal fatigue and sleepiness may reduce physical activity.
• Slower Weight Loss: Metabolic adaptation and hormonal responses may affect the rate of weight loss.

Why Is Abdominal Fat Accumulation Important?

Abdominal fat accumulation is an important indicator for insulin resistance and metabolic diseases. Body mass index shows a person’s general weight status, but it does not show where fat is accumulated. Therefore, waist circumference measurement is a valuable parameter, especially in metabolic risk assessment.

An increase in waist circumference may be an indicator of visceral fat accumulation. Visceral fat tissue accumulates around organs such as the liver, pancreas and intestines. This type of fat accumulation may be seen together with blood sugar imbalance, high triglycerides, low HDL, fatty liver and high blood pressure.

The reasons why abdominal fat accumulation is important include:

• Being Metabolically Active: Visceral fat tissue may secrete hormones and inflammatory signals.
• Increasing Type 2 Diabetes Risk: It may increase diabetes risk together with insulin resistance.
• Being Associated With Fatty Liver: It may negatively affect liver metabolism.
• Being Linked To Cardiovascular Risk: It may be seen together with cholesterol, triglyceride and blood pressure abnormalities.
• Showing More Than Weight Follow-Up: Even if the weight on the scale does not change, waist circumference may provide information about metabolic risk.

Insulin Resistance, Obesity And Type 2 Diabetes Risk

When insulin resistance and obesity occur together, the risk of type 2 diabetes may increase. At first, the pancreas tries to keep blood sugar at a normal level by producing more insulin. However, over time, the capacity of the pancreas to maintain this balance may decrease. In this process, prediabetes and then type 2 diabetes may develop.

The World Health Organization states that type 2 diabetes is associated with modifiable risk factors such as excess weight, physical inactivity and unhealthy diet. It also emphasizes that the risk of type 2 diabetes can be reduced by maintaining a healthy body weight, being physically active, eating a healthy diet and avoiding tobacco use.

The key points showing this relationship are:

• Insulin Resistance May Be The First Step: Insulin levels may rise before blood sugar deteriorates.
• Prediabetes May Develop: Blood sugar rises above normal but may not reach the diabetes threshold.
• Type 2 Diabetes Risk May Increase: The pancreas may not meet the high insulin need for a long time.
• Weight Management May Reduce Risk: Healthy weight loss may support insulin sensitivity.
• Regular Follow-Up Enables Early Intervention: HbA1c, fasting glucose and lipid profile help monitor risk.

Does Obesity Always Mean Insulin Resistance?

Obesity increases the risk of insulin resistance; however, it cannot be said that everyone with obesity has the same level of insulin resistance. In some people, blood sugar, insulin and lipid values may remain better for a long time. On the other hand, some people with normal weight may develop insulin resistance due to abdominal fat accumulation, genetic predisposition or sedentary lifestyle.

Therefore, metabolic evaluation should not be based only on body weight or appearance. The person’s waist circumference, blood pressure, fasting blood glucose, fasting insulin, HbA1c, triglycerides, HDL cholesterol and liver enzymes should be evaluated together. This approach provides a more accurate understanding of risk.

Points to consider on this issue include:

• Weight Alone Is Not Enough: Two people with the same weight may have different metabolic risks.
• Waist Circumference Is Important: Where fat accumulates may be decisive in terms of health risk.
• Blood Values Are Guiding: Fasting glucose, HbA1c, insulin and lipid profile should be interpreted together.
• Risk May Exist At Normal Weight: Insulin resistance may develop due to inactivity and genetic predisposition.
• Individualized Follow-Up Is Needed: Treatment and follow-up plan should be created according to individual risks.

Which Values Should Be Monitored In Insulin Resistance And Obesity Follow-Up?

The aim in insulin resistance and obesity follow-up is not only to see weight loss. Blood sugar, insulin level, lipid profile, liver enzymes, kidney function and blood pressure should be evaluated together to understand how metabolic health changes. This approach provides a more reliable framework in medical follow-up.

The American Diabetes Association 2026 standards emphasize that obesity and weight management are important topics in the prevention and treatment of diabetes. In obesity evaluation, not only weight but also accompanying diseases, cardiometabolic risks and treatment goals should be considered together.

The main measurements that may be evaluated during follow-up include:

• Fasting Blood Glucose: This is one of the basic indicators of glucose metabolism.
• Fasting Insulin And HOMA-IR: These may provide an idea about insulin resistance.
• HbA1c: This shows the average blood sugar of the last 2-3 months.
• Lipid Profile: This includes LDL, HDL, total cholesterol and triglyceride values.
• ALT, AST And GGT: These may be evaluated in terms of fatty liver and metabolic health.
• Creatinine And eGFR: These may be used to monitor kidney function.
• Waist Circumference And Blood Pressure: These are important in cardiometabolic risk assessment.

Can Weight Loss Reduce Insulin Resistance?

Healthy and sustainable weight loss may improve insulin sensitivity in many people. Especially the reduction of fat tissue around the abdomen may have positive effects on blood sugar control and metabolic values. However, the speed, method and sustainability of weight loss should be planned individually.

NIDDK states that healthy lifestyle habits and weight management are important for preventing or reversing insulin resistance and prediabetes. Health professionals may also plan medication treatment in some people for blood sugar management, weight loss and prevention of type 2 diabetes.

Areas that weight loss may support include:

• Insulin Sensitivity: The response of cells to insulin may improve.
• Blood Sugar Balance: Improvement may be seen in fasting glucose and HbA1c values.
• Triglyceride Level: Positive changes may occur in blood fats.
• Fatty Liver: Reduction in fat tissue may support liver metabolism.
• Blood Pressure: Weight loss may contribute to blood pressure control.

When Is Medical Support Needed?

Insulin resistance and obesity may not always be managed only with diet and exercise. Medical support is important especially if there is risk of type 2 diabetes, prediabetes, hypertension, fatty liver, high triglycerides, rapid weight gain or previous unsuccessful weight loss attempts.

Medical support includes interpretation of blood tests, personalization of nutrition and exercise plans, evaluation of accompanying diseases and, when necessary, planning medication treatment. GLP-1 treatments or other medical approaches should be planned only after physician evaluation, considering the person’s risks and needs.

Situations that may require medical support include:

• Elevated HbA1c: Evaluation should be performed for prediabetes or diabetes.
• High HOMA-IR: It should be interpreted together with clinical findings and other tests.
• Significant Increase In Waist Circumference: It should be examined in terms of metabolic risk.
• Fatty Liver: It should be followed more closely together with insulin resistance.
• Difficulty Losing Weight: Underlying hormonal or metabolic causes may be investigated.
• Possibility Of Medication Treatment: Endocrinology evaluation may be needed for GLP-1 or other treatments.

Happ Health And Online Endocrinology Doctor Support

Insulin resistance and obesity are metabolic processes that should not be evaluated only through weight or blood sugar. When waist circumference, HbA1c, fasting insulin, HOMA-IR, cholesterol, triglycerides, liver enzymes and kidney function are considered together, the person’s health risk is understood more accurately.

Happ Health is a digital health platform that facilitates access to specialist physician support in endocrinology through its online health application. For evaluation related to insulin resistance, obesity, prediabetes, GLP-1 treatment or type 2 diabetes risk, you can plan an online endocrinology doctor consultation and receive professional support in interpreting your blood values according to your personal health status.

References

• World Health Organization, Obesity And Overweight Fact Sheet
  https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight
• World Health Organization, Obesity Health Topic Page
  https://www.who.int/health-topics/obesity/obesity
• World Health Organization, Diabetes Fact Sheet
  https://www.who.int/news-room/fact-sheets/detail/diabetes
• World Health Organization, Diabetes Health Topic Page
  https://www.who.int/health-topics/diabetes
• World Health Organization, Global Diabetes Compact
  https://www.who.int/initiatives/the-who-global-diabetes-compact/
• National Institute Of Diabetes And Digestive And Kidney Diseases, Insulin Resistance And Prediabetes
  https://www.niddk.nih.gov/health-information/diabetes/overview/what-is-diabetes/prediabetes-insulin-resistance
• American Diabetes Association, Standards Of Care In Diabetes 2026
  https://professional.diabetes.org/standards-of-care
• American Diabetes Association, Obesity And Weight Management For The Prevention And Treatment Of Diabetes 2026
  https://diabetesjournals.org/care/article/49/Supplement_1/S166/163915/8-Obesity-and-Weight-Management-for-the-Prevention